Introduction
Over the course of the last 20 year telemedicine introduced various concepts and methods to bridge the spatial gap between practitioner, medical service professional and patient. But most of these approaches could not make it to the width of medical care due to lack of evidence and practicality [1] . Approaches were established with focus on pure data transmission as well as alarm functionality, consultation and therapy management.
While in general, telemedical methods differ over a wide range, some recurring common patterns exist (Fig. 1) . Between different approaches, most variation is found in the spatial distances and quality and quantity of communicated data. This review aims to give an overview of the capabilities of interventional decentralised telemonitoring (idTM) as an individual patient-centered tool for diagnosis and therapy focusing on blood pressure and body-weight as relevant parameters for various diseases.
The increasing demand for telemedical solutions is caused by a wealth of, in parts independent, developments [2, 3] . Besides ageing societies and an increase [4, 5] in chronic diseases with earlier onset [6] , centralisation of medical competence and a decline in medical service coverage of rural areas [7, 8] , increasing social isolation and the loss of support networks inside and outside of families [9, 10] as well as higher expectations to therapy standards are to name [11] .
Moreover, these factors result in a higher number of visits to the general practitioner per patient contributing to the strain on resources in the health sector [12, 13] . There exist claims that telemedicine cannot be the answer to requirements arising from an ageing demographic, as the elderly patients are challenged to operate the employed technology adequately [14] . Numerous studies have however found no indication that this is true and the argument can be dismissed [15] [16] [17] [18] .
Following the requirements of the Federal joint committee (G-BA) -as the highest decision-making body of the joint self-government of physicians, dentists, hospitals and health insurance funds in Germany -of the year 2013 for the evaluation of safety, effectiveness and necessity of the respective telemedicine application, the involved doctors need to prove understanding the disease and its context as well as provide prove of medical feasibility as well as cost efficiency of the approach.
Interventional decentralised telemonitoring (idTM)
A special form of telemedicine applications is the interventional decentralised telemonitoring in which the individual patient-practitioner situation motivates therapy management and optimisation on the basis of telemedical obtained data [19] .
The success of the approach can, in addition to the need for therapy optimisation and its relevance in socio-economic context, be attributed to the practitioner providing continuous and individual supervision, who understands the context of the treated condition as well as idTM including possible resulting individual alarm conditions and consequences for therapy parameters (Tab. 1). Beyond the automated measurement, the patient does not need to take action for the results to be transmitted. This is comfortable and reliable, as it enables also the elderly, not necessarily technologically versed patient to provide reliable, authentic data for the therapy to the general practitioner as well as medical service and care staff.
To identify possible indication areas, a detailed assessment and definition of transferred parameters, alarm conditions, intervention algorithms is necessary in addition to an analysis of cost efficiency [20] .
Technological background
Telemonitoring describes the transmission of telemetry by means of a combination of medical technology and a mobile phone or modem. Medical technologies here are measurement devices such as scales or blood pressure monitors. The data acquired by the patient are either electronically stored and transmitted in regular intervals or transmitted immediately after a measurement has completed. In most technical approaches, the data transmission is performed by a mobile or modem set up for the task and coupled to the measurement device, e.g. via Bluetooth. The data are send to a database. Measurements are encapsuled in a proprietary protocol allowing correlation of patient, measurement device and measurement. This coordinated communication approach ensures all data arrive complete and correct with the receiver. Individually defined thresholds trigger automatic notification of the practitioner and, if applicable, the patient as well by SMS, e-mail or fax ( Fig. 2 and 3) .
Communicated measurements can be accessed using a web browser as well; merely an internet connection is needed. Providing authentication information, the individual practitioner gains access to all of his patient's data and is granted rights to create new patient data sets and associate of measurement devices with patients. Furthermore individual settings and alarm conditions can be defined here.
To ensure secure data transfer between the database and user, the connection is encrypted by SSL. This tap-proof connection using the https protocol is state of the art. In addition to transmission of telemedicine data, the subsequent storage and management of collected data is of great importance. Legal requirements and further reaching patient concernes need to be addressed by providing servers with definite geographical location and well defined access rights.
Regarding diagnostics and therapy, the practitioner can evaluate the data in the context of the individual patient history and initiate further actions where necessary. These may consist e.g. of contacting the patient by phone and readjusting the therapy (Fig. 3) .
In the future, communication through a smartphone with application and corresponding sensor could be considered. Currently there are neither certified sensors on the market nor secure data transmission available. Applications, like Apple Healthbook (iOS 8), can currently only act as a blood pressure diary and are not recommended by the German Hypertension League (DHL) due to lack of plausibility check of documented data. 
Arterial Hypertension
Hypertension is the leading risk factor for early death [21] with high prevalence and mortality in Europe [22] . The prevalence in men between 45 and 54 years of age in Germany lies between 40 and 70 per cent [23] , in Switzerland at approximately 46 per cent [24] . Despite the fact that persisting hypertension is causing cardiovascular disease while adequate treatment is significantly reducing morbidity and mortality [25] , the quality of therapy has remained static at the same level for years. Worldwide only 34 per cent of hypertension patients reach blood pressure values below 140/90 mmHg [26] . In Germany this number is even lower at between 10 and 25 per cent [27] . The main cause for this situation is suboptimal pharmaceutical therapy including incomplete dose titration and an insufficient number and combination of antihypertensive drugs to reach levels recommended by the the ESH/ESC guidelines. At the same time, especially with patients at high vascular risks like diabetics and patients with renal insufficiency antihypertensive over-medication has to be avoided as well [28] .
To reach the goals of therapy outlined above, frequent (every 2 weeks) visits to the practice are recommended during the medication titration phase [29] . The resulting time constraints in the patient practitioner contact reduce quality of treatment, adherence to medication, persistency and compliance [30] .
Blood pressure values in the morning are strongly correlated with cerebrovascular events [31, 32] . The American Heart Association is therefor suggesting an observation regime comprising two measurements in the morning and in the evening, respectively [33] .
Studies document that data recorded by the patient do differ from automatic measurements stored in blood pressure monitoring devices [34, 35] . Moreover the doctor cannot directly relate these data to side effects like symptomatic hypo-or hypertension reported by the patient, e.g. on the phone which might lead to wrong therapy decisions.
In this light, the remote observation by means of telemetrical blood pressure monitoring (TBPM) in particular intervententional decentralized telemetrical blood pressure monitoring (idTBPM) [36] or similar approaches seem to be a good way to enable early assessment of the patient reaction to the respective antihypertensive medication. idTBPM strengthens trust and confidence of the practitioner in the process of individual medication titration and serves to improve the adherence to medication of the patient. Especially idTBPM of blood pressure in the morning is having an important role in the prevention of hypertension events as only meaningful data here can document the necessity to lower the blood pressure during the night and in the early morning by additional antihypertensive medication late in the evening [37] .
The feasibility of the approach for use in practice has been proven by a study on former inadequately treated hypertension patients [36] . In a randomised setup, 60 patients received in addition to their existing medication Irbesartan in a dose of up to 600mg daily, taking in to consideration either only an initial ABPM measurement or additional telemetric measurements over the course of three months. Patients under telemetric observation (Fig.  1) exhibited a more pronounced reduction of systolic blood pressure (-15.8 mmHg compared to -8.1 mmHg in the control group) in an ABPM measurement commenced after 3 month at the end of the study. The significantly better reduction of blood pressure can be explained by adequate dose titration including an additional dose of the Angiotensin receptor antagonist late in the evening. Furthermore, a long term follow-up study showed a long lasting impact of the telemedical intervention, having an effect for on average 20 months [38] . Amongst other things, the cost effect balance of the method is currently subject of the study EDIMED. Here, first analyses suggest safety of the method and the feasibility of its implementation in practice [39, 40] .
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Hemodialysis -Interdialytic weight gain and arterial hypertension
Neither blood pressure measurements during dialysis sessions, nor ambulant 24h blood pressure monitoring are reflecting the actual blood pressure dynamics of dialysis patients accurately. This is especially problematic in the context of the very narrow desired blood pressure range for these high risk patients.
The most reported symptom in patients receiving chronic hemodialysis is tantalising thirst. This fact leads to widespread non-compliance with liquid intake quotas (74 per cent of all hemodialysis patients) resulting in chronic hypervolemia and following therapy resistant hypertension, left ventricular hypertrophy, cardiac insufficiency and pulmonary complications [41] .
These factors combined with extended hypotensive episodes during and after dialysis caused by the necessary high fluid removal rate associated with high ultrafiltration rates per hour lead to increased mortality and a larger number of vascular complications [42] .
As psychological and pedagogical interventions do not help to improve compliance with liquid intake quotas [43] , telemetrical body weight monitoring (TBWM) is a promising approach to reduce the daily fluid intake and thereby the interdialytic weight gain (IWG) of these patients.
In combination with telemetric blood pressure monitoring (TBPM) a new strategy for individual antihypertensive therapy of this specific patient type might be devised (s.a.).
After 3 months of body weight telemetry, the IWG in the second week interval (e.g. Wednesday to Friday) as well as the average weekly IWG were significantly reduced as compared to controls. Required ultrafiltration rate and systolic blood pressure at the start of dialysis were reduced, while there was a tendency of a rise in diastolic blood pressure after 3 months of TBPM [44] .
Hypertension during pregnancy
During the first half of pregnancy, physiological changes introduce a slight decrease in blood pressure exhibiting a valley between the 16th and 20th week of pregnancy due to a reduction in systemic vascular resistance [45] . With respect to 24h monitoring, this phase is characterised by a strong reduction over night [46] , which vanishes starting from week 22nd Here, the norm level of 140/90 mmHg should however be not exceeded [47] . In about 10 per cent of pregnancies, during the last third so called hypertension of pregnancy occurs, designated by an increase of systolic blood pressure above 140 mmHg and/or diastolic blood pressure above 90 mmHg [47] .
The telemetric monitoring and attendance of the patients can help to reduce or shorten hospitalisations for monitoring, blood pressure management and avoidance of complications [48] , while as well provide indication for hospital treatment in good time, as a rise in blood pressure is the most important criterium for the diagnosis of a pre-eclamptic condition. Rises of 30 mmHg systolic or 15 mmHg diastolic are dangerous. In younger women having their first child and presenting blood pressure values between 100-110/60-70 mmHg in the second trimenon however, a blood pressure of 130/80 already indicates a significant increase or "relative" hypertension. Here, lacking night reduction in blood pressure is the condition crucial to diagnosis [46, 49] . It can be reliably diagnosed by a self-measurement in the early morning [32] .
Hypertension related complications during pregnancy
After the 20th week of pregnancy the pregnancy specific forms of hypertension often occur, characterised by hypertension and proteinuria, pre-eclampsia and superimposed pre-eclampsia and their most severe forms, eclampsia and HELLP syndrome are the most dangerous diseases in which pathogenesis general vascular (endothelial) dysfunction is of importance [50] . Patients at risk therefor require very close and reliable monitoring of blood pressure and body weight as it can be provided by idTM.
Hypertension related complications during pregnancy occur in about 5 to 10 per cent of all pregnancies [51] . They are among the leading causes for maternal and perinatal mortality [52] . The relation of perinatal mortality and blood pressure is u-shaped [53] in that not only too high, but also too low blood pressure values introduce the risk of perinatal mortality and threaten the healthy development of the child [53, 54] .
If hypertensive values are registered by self-monitoring, an additional ambulant 24h measurement (ABPM) is indicated, to exclude possible circadian blood pressure rhythmicity [55] common in pre-eclamptic conditions, severe forms and risk patients as sporadically recorded blood pressure values in the morning or over the course of the day do not adequatly reflect the risk in the context of preeclampsia.
Hypertension, proteinuria and formation of edama are the main symptoms of preeclampsia [56] . Daily measurement of body weight by means of the "telemetric" scale is already implemented in practice for high risk pregnancies and helps to hospitalise the patients not unnecessarily but in good time (Fig. 1) . Outcome studies on this are however still pending.
Antihypertensive therapy during pregnancy
Meta analyses suggest positive effects of antihypertensive therapy during pregnancy for the mother, but rather negative impact on the newborn [57] with rarely occurring severe hypertension under antihypertensive medication in mild to intermediate cases of hypertension as well as reduced birth weight and increased cases of growth retardation [58] .
This explains the cautious approach to antihypertensive medication therapy for pregnant women exhibiting mild to intermediate hypertension, where non-medication measures like reduced physical activity or a temporary break from work are favoured. There is a consensus with respect to restricting therapy by medication to cases of severe hypertension only, i.e. in cases of blood pressure exceeding 170/110 mmHg or toxemia of pregnancy respectively [59] .
This makes close and reliable, meaningful blood pressure monitoring even more important in order to correctly time a possibly necessary early induction of labour as well as to identify antihypertensive over-medication (Fig. 1) . Thus, TBPM is very well suited for therapy management in the outpatient sector.
Conclusion
Blood pressure monitoring for arterial hypertension TBPM is effective and first results on its cost efficiency confirm it as a feasible method for the optimisation of blood pressure monitoring.
Body weight and blood pressure monitoring in hemodialysis patients
TBWM is an effective method to optimise IWG as well as to reduce ultrafiltration rates and diastolic blood pressure levels in hemodialysis patients. Hospitalisation and diastolic hypotension during dialysis can be avoided. In combination with TBPM a possible antihypertensive therapy which is adjusted to the weekly dialysis rhythm and the resulting variations in volume status is conceivable. Long term studies on the duration of effects on IWG and mortality and hospitalisation rates are pending. Based on the results of the ongoing EDIMED study, these would allow for a cost efficiency analysis. A first data analysis already Schulz/Neumann: Interventional Decentralized Telemonitoring shows a lower time spent on processes in the doctor's office compared to standard treatment of hypertension. A final data analysis is done currently.
Body weight and blood pressure monitoring in pregnant patients
The dynamics of blood pressure levels and body weight are two very important parameters for the course of a pregnancy. Both too low as well as too high blood pressure levels can have negative effects on the development of the fetus. Too high weight gain poses a risk even without hypertension.
Telemetry methods enable the daily transfer of blood pressure and weight data to the medical practice and thus short response times. Developing risks can be recognised early and possible complications effectively counteracted. Therefor TBWM and TBPM may prove to be an effective method to prevent hypertension related complications during high risk pregnancies. Here randomised outcome studies are still required.
Interventional decentralised telemonitoring (idTM)
IdTM is providing the practitioner with a tool for the optimal monitoring and therapy management of her or his patients. The transferred parameters and alarm algorithms are here dependent on the indications for which evidence of effectiveness of telemetrical methods has been provided to different extend. The amplification of the existing practitioner patient relationship, the avoidance of vast data volumes by well defined alarm criteria as well as its limited runtime and immediate impact on therapy decisions set idTM apart from other telemedical applications dominated by centralised approaches.
For further investigation of functionality and use of iTBPM a study register (EUSTAR -European Society of Hypertension Arterial hypertension in Telemedicine Register) was established under the auspices of the European Society of Hypertension (ESH). In this register will now examine these special indications described above with detailed definition of communicated parameters, alarm rules and algorithms of intervention for in the width of the ESH Hypertension Excellence Centers.
The following indications are planned in form of sub-registers: hypertension, hypertension in children and adolescents, pregnancy hypertension, dialysis, post-transplant, post-intervention, post-stroke and chronic heart failure. The start of the registry is scheduled for mid 2015 and is currently in detailed elaboration.
Not least now must be noted -the quality of a telemedical method can be related to the quality of the medical decisions derived from its application, making intensive training in institutions employing idTM by doctors specialised in the respective area of indication, indispensable. 
Disclosure Statement
The authors of this manuscript state that they do not have any conflict of interests and nothing to disclose.
